Search results
Dr Reddy's Labs targets double-digit India growth for FY25
CNBC Awaaz· 1 day agoWith sales of Rs 1,330 crore in Q1 of FY25, Dr. Reddy's ranks 10th in the domestic market, according...
Gland Pharma, Zydus Lifesciences secure USFDA approvals for key medications
Business Standard India· 6 days agoGland Pharma USFDA approvals: Gland Pharma, a Hyderabad-based generic injectable-focused company,...
Alkem Laboratories Ltd Management Discussions | India Infoline
India Infoline· 5 days agoAlkem Laboratories Ltd Management Discussions: Check out the latest updates, and news about the Alkem Lab management discussions at India Infoline
Zydus Life stock price jumps 6% on USFDA nod for Valsartan tablets
Business Standard India· 5 days agoZydus Life Share Price: The shares surged after the pharmaceutical major announced that it has...
Cipla net profit jumps 17.4% to Rs 1,178 crore in Q1FY25
The Economic Times· 3 days agoDrug maker Cipla reported a 17.4% year-on-year (YoY) jump in net profit to Rs 1,178 crore in Q1FY25,...
Zydus Lifesciences gets USFDA's final approval for hypertension drug - CNBC TV18
CNBC TV18· 6 days agoZydus Lifesciences Ltd has received final approval from the United States Food and Drug...
Cipla Q1 Results: Cons PAT rises 18% YoY to Rs 1,178 crore, beats estimates
The Economic Times· 3 days agoPharma major Cipla on Friday posted 18% growth in its consolidated net profit at Rs 1,178 crore for the first quarter ended June 2024. The same stood at Rs 996 crore in the year-ago period.
Zydus Life gets final approval from USFDA for hypertension drug
Business Standard India· 6 days agoZydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to market Valsartan tablets.
Zydus Lifesciences wins FDA nod for Valsartan Tablets | India Infoline
India Infoline· 5 days agoZydus Lifesciences Ltd has obtained final approval from the United States Food and Drug Administration (FDA) for Valsartan Tablets, which are used to treat hypertension. The FDA has granted ...
Zydus Lifesciences secures USFDA approval for Zituvimet XR | India Infoline
India Infoline· 7 days agoZydus Lifesciences announced that it has received final approval from the US Food and Drug Administration (USFDA) for its new drug application (NDA) for a diabetes medication. The approval is ...